ATH 33.3% 0.4¢ alterity therapeutics limited

PBT434 inhibits alpha- synuclein in the brain., page-4

  1. 5,921 Posts.
    lightbulb Created with Sketch. 151
    Makes you wonder why they would bury that A-Syn gem in the middle of the cash flow announcement
    https://alteritytherapeutics.com/investor-centre/news/2019/08/01/quarterly-cash-flow-report/

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.